Certified by Founder Lodge
Antiverse
United Kingdom - Cardiff, Wales
START UP
1 Disclosed Funding Rounds $3,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen bindin
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 03 ,2023 | Unknown | $3,000,000 | |
| October, 16 ,2024 | Seed | $4,576,060 |
Kadmos Capital Ltd
Innospark Ventures
Development Bank of Wales
Deep Science Ventures
Tensor Ventures
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)